Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Simeon George | Director | 2025-07-16 | 6,510 | $52.03 | $338.72kBuy |
Simeon George | Director | 2025-07-16 | 22,319 | $52.03 | $1.16MBuy |
Simeon George | Director | 2025-07-16 | 960,983 | $52.03 | $50.00MBuy |
Naimish Patel | Chief Medical Officer | 2025-05-29 | 3,932 | $35.94 | $141.32kSell |
Samarth Kulkarni | Chief Executive Officer | 2025-03-21 | 10,031 | $41.23 | $413.58kSell |
Julianne Bruno | Chief Operating Officer | 2025-03-21 | 1,714 | $41.23 | $70.67kSell |
Raju Prasad | Chief Financial Officer | 2025-03-21 | 2,197 | $41.23 | $90.58kSell |
James R. Kasinger | General Counsel and Secretary | 2025-03-21 | 3,185 | $41.23 | $131.32kSell |
Raju Prasad | Chief Financial Officer | 2025-03-17 | 3,762 | $41.80 | $157.25kSell |
James R. Kasinger | General Counsel and Secretary | 2025-03-12 | 1,116 | $43.32 | $48.35kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ark Investment Management LLC | 11.77% | 10,165,400 | $648.04M | Institution |
Celgene Corp | 9.91% | 8,557,514 | $545.54M | Insider |
Capital International Investors | 7.03% | 6,073,118 | $387.16M | Institution |
Vertex Pharmaceuticals Europe Ltd | 6.23% | 5,380,940 | $343.03M | Insider |
Simeon George | 6.09% | 5,259,390 | $335.29M | Insider |
Bayer Global Investments Bv | 5.91% | 5,105,330 | $325.46M | Insider |
T Rowe Price Investment Management Inc | 4.40% | 3,798,103 | $242.13M | Institution |
Glaxosmithkline PLC | 3.73% | 3,220,627 | $205.31M | Insider |
Blackrock Inc | 3.03% | 2,613,539 | $166.61M | Institution |
Sumitomo Mitsui Trust Group Inc | 2.94% | 2,539,889 | $161.92M | Institution |